Recommendations for inhaled nitric oxide treatment in the newborn

J. Figueras Aloy, F. Castillo Salinas, D. Elorza Fernández, M. Sánchez-Luna, J. Pérez Rodríguez, E. Doménech, M. C. López Herrera, I. Izquierdo, A. Losada, J. Perapoch

    Research output: Contribution to journalArticleResearchpeer-review

    1 Citation (Scopus)


    The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for iNO administration, its dosage and the main secondary effects are discussed, and the reasons for lack of response to this treatment are analyzed.
    Original languageEnglish
    Pages (from-to)260-266
    JournalAnales de Pediatria
    Issue number3
    Publication statusPublished - 1 Jan 2006


    • Inhaled nitric oxide
    • Newborn
    • Pulmonary hypertension


    Dive into the research topics of 'Recommendations for inhaled nitric oxide treatment in the newborn'. Together they form a unique fingerprint.

    Cite this